Heart failure with preserved ejection fraction in Belgium: characteristics and outcome of a real-life cohort

References

• Lam CSP, Voors AA, de Boer RA, et al. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018;39(30):2780–2792.
   PubMed Web of Science ®Google Scholar
• Zile MR, Baicu CF, Ikonomidis JS, et al. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation. 2015;131(14):1247–1259.
   PubMed Web of Science ®Google Scholar
• Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–271.
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602.
   PubMed Web of Science ®Google Scholar
• Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476–2486.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776–803.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, Document Reviewers, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.
   PubMed Web of Science ®Google Scholar
• Policies OEOoHSa. Belgium: Country Health Profile 2017, State of Health in the EU. OECD publishing, Paris/European Observatory on Health Systems and Policies, Brussels, 2017.
   Google Scholar
• Gevaert AB, Boen JRA, Segers VF, et al. Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology. Front Physiol. 2019;10:638.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Rizkala AR, Lefkowitz MP, et al. Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018;11(7):e004962.
   PubMed Web of Science ®Google Scholar
• Shah AM, Cikes M, Prasad N, et al. Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2019;74(23):2858–2873.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Rizkala AR, Gong J, et al. Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF Trial. JACC Heart Fail. 2017;5(7):471–482.
   PubMed Web of Science ®Google Scholar
• Tromp J, Teng TH, Tay WT, on behalf of the ASIAN-HF Investigators, et al. Heart failure with preserved ejection fraction in Asia. Eur J Heart Fail. 2019;21(1):23–36.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, Houston, Texas; Oslo, Norway; Phoenix, Arizona; Nashville, Tennessee; Hamilton, Ontario, Canada; Uppsala, Sweden; Ghent and Liège, Belgium; Cleveland, Ohio; Novara, Italy; Rochester, Minnesota; Bucharest, Romania; and St. Louis, Missouri, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–1360.
   PubMed Web of Science ®Google Scholar
• Sartipy U, Dahlstrom U, Fu M, et al. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail. 2017;5(8):565–574.
   PubMed Web of Science ®Google Scholar
• Kotecha D, Lam CS, Van Veldhuisen DJ, et al. Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins. J Am Coll Cardiol. 2016;68(20):2217–2228.
   PubMed Web of Science ®Google Scholar
• Kotecha D, Chudasama R, Lane DA, et al. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol. 2016;203:660–666.
   PubMed Web of Science ®Google Scholar
• Mentz RJ, Kelly JP, von Lueder TG, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64(21):2281–2293.
   PubMed Web of Science ®Google Scholar
• Van der Heyden J, Charafeddine R, editors. Enquête de santé 2013. Rapport 1 : Santé et Bien-être. Résumé des principaux résultats D/2014/2505/53 – Institut scientifique de santé publique. https://his.wiv-isp.be/fr/Documents%20partages/summ_HS_FR_2013.pdf
   Google Scholar
• Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598–1617.
   PubMed Web of Science ®Google Scholar
• Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90.
   PubMed Web of Science ®Google Scholar
• Senni M, Paulus WJ, Gavazzi A, et al. New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. Eur Heart J. 2014;35(40):2797–2815.
   PubMed Web of Science ®Google Scholar
• Tromp J, Shen L, Jhund PS, et al. Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. 2019;74(5):601–612.
   PubMed Web of Science ®Google Scholar
• The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012;33:1750–1757.
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Patel RB, Michel A, et al. Mode of death in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2017;69(5):556–569.
   PubMed Web of Science ®Google Scholar
• Chan MM, Lam CS. How do patients with heart failure with preserved ejection fraction die?. Eur J Heart Fail. 2013;15(6):604–613.
   PubMed Web of Science ®Google Scholar
• Iorio A, Senni M, Barbati G, et al. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study. Eur J Heart Fail. 2018;20(9):1257–1266.
   PubMed Web of Science ®Google Scholar
• Ergatoudes C, Schaufelberger M, Andersson B, et al. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry. Clin Res Cardiol. 2019;108(9):1025–1033.
   PubMed Web of Science ®Google Scholar
• Wohlfahrt P, Redfield MM, Lopez-Jimenez F, et al. Impact of general and central adiposity on ventricular-arterial aging in women and men. JACC Heart Fail. 2014;2(5):489–499.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Osman AF, Milani RV, et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91(7):891–894.
   PubMed Web of Science ®Google Scholar
• Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61.
   PubMedGoogle Scholar
• Kapoor JR, Heidenreich PA. Obesity and survival in patients with heart failure and preserved systolic function: a U-shaped relationship. Am Heart J. 2010;159(1):75–80.
   PubMed Web of Science ®Google Scholar
• Banack HR, Stokes A. The 'obesity paradox' may not be a paradox at all. Int J Obes (Lond). 2017;41(8):1162–1163.
   PubMed Web of Science ®Google Scholar
• Vest AR, Wu Y, Hachamovitch R, et al. The heart failure overweight/obesity survival paradox: the missing sex link. JACC Heart Fail. 2015;3(11):917–926.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Carbone S, Agarwal MA. An obesity paradox with myocardial infarction in the elderly. Nutrition. 2018;46:122–123.
   PubMed Web of Science ®Google Scholar
• Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61(2):142–150.
   PubMed Web of Science ®Google Scholar